Investors
Modernizing home oxygen therapy.
Dosehost is a Canadian medical-device company building intelligent oxygen therapy technology for patients at home.
SeedPre-revenue
The market
$2.5B
North America oxygen concentrators by 2027
Frost & Sullivan
1.5M+
Americans on long-term home oxygen
American Thoracic Society, 2020
$6.6B
US home medical equipment rental by 2030
IBISWorld, 2025
What we're building
Intelligent oxygen therapy technology that adapts to each patient, with the data to support care at home. Technical detail is shared under NDA.
Why now
- 1 in 5 COPD hospital stays leads to a readmission within 30 days.
- Home oxygen therapy has barely changed in decades.
- Care is moving home, and payers want visibility into it.
The team
Respiratory clinicians
People who have treated these patients.
Device and software engineers
People who have shipped regulated hardware.
Former home oxygen operators
People who have run the service side.
Request the data room
Accredited investors can review the full package under NDA.
Or email investors@dosehost.com
This page is for information only and is not an offer to sell securities. Terms are shared only with qualified investors under NDA.